Latest Breaking News On - Leukocyte interleukin - Page 1 : comparemela.com

CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results

CEL-SCI Corporation today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments. Clinical and Corporate Developments.

United statesGeert kerstenSecurities exchangeEuropean unionDrug administrationExchange commissionEuropean medicines agency paediatric committeeCorporate developmentsRegistration studyEuropean medicines agencyPaediatric committeeLeukocyte interleukinOrphan drugSecurities actSecurities exchange act

CEL-SCI Corp (CVM) Receives FDA Go-Ahead for Confirmatory Study of Multikine

CEL-SCI Corp (CVM) Receives FDA Go-Ahead for Confirmatory Study of Multikine
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGeert kerstenDrug administrationLeukocyte interleukinRegistration study

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

CEL-SCI Corporation today announced the appointment of Mario Gobbo to its Board of Directors. Mr. Gobbo has nearly 40 years of banking and corporate finance experience in healthcare and energy..

United statesOcimum genelogicMario gobboGeert kerstenSecurities exchangeEuropean bankExchange commissionNatixis bleichroeder incInternational finance corporationWharton school of the university pennsylvaniaHarvard collegeSwiss bank corporationWorld bankUniversity of coloradoNatixis bleichroederNorganic chemistry

CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results

CEL-SCI Corporation today reported financial results for the quarter ended December 31, 2023, as well as key recent clinical and corporate developments. Clinical and Corporate Developments.

United statesExchange commissionSecurities exchangeEuropean society for medical oncologyCorporate developmentsLeukocyte interleukinMedical oncologyOrphan drugSecurities actSecurities exchange act

CEL-SCI Announces Closing of $7 75 Million Public Offering of Common Stock

CEL-SCI Announces Closing of $7 75 Million Public Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkExchange commissionSecurities exchangeLeukocyte interleukinOrphan drugSecurities actSecurities exchange act